Skip to main content

Table 3 Total and incremental costs and effects

From: Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

 

ST

ERT

Difference

[95% confidence interval]

Life expectancy (years)

0.40

13.79

13.39

[1.55 – 25.23]

QALYs

0.24

7.00

6.75

[2.32 – 11.19]

Total costs

€ 32,871

€ 7,032,899

€ 7,000,028

[1,869,635 – 12,130,422]

- ERT costs

€ -

€ 6,630,525

€ 6,630,525

[1,615,059 – 11,645,991]

- Infusion costs

€ -

€ 212,793

€ 212,793

[121,477 – 304,108]

- Other costs

€ 32,871

€ 189,582

€ 156,711

[131,728 – 181,694]

  1. ST supportive therapy, ERT enzyme replacement therapy, QALY quality adjusted life year.